IMM 1.45% 34.0¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-25

  1. 2,618 Posts.
    lightbulb Created with Sketch. 326
    The “competitive tension”isn’t reflective of our current share price
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.